Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: Report of an autopsy case
Authors:
- 25 March 2014
- journal article
- case report
- Published by Wiley in Neuropathology
- Vol. 34 (4) , 414-419
Abstract
We report clinicopathological features of a 23‐year‐old woman with Down syndrome (DS) presenting with subacute myelopathy treated with chemotherapy, including intravenous and intrathecal administration of methotrexate (MTX), and with allogenic bone‐marrow transplantation for B lymphoblastic leukemia. Autopsy revealed severe demyelinating vacuolar myelopathy in the posterior and lateral columns of the spinal cord, associated with macrophage infiltration, marked axonal loss and some swollen axons. Pathological changes of posterior and lateral columns were observed from the medulla oblongata to lumbar cord. Proximal anterior and posterior roots were preserved. Cerebral white matter was relatively well preserved. There were no vascular lesions or meningeal dissemination of leukemia. Longitudinal extension of cord lesions was extensive, unlike typical cases of subacute combined degeneration (SACD), but distribution of lesions and histological findings were similar to that of SACD. DS patients show heightened sensitivity to MTX because of their genetic background. Risk factors for toxic myelopathy of DS are discussed, including delayed clearance of MTX despite normal renal function, alterations in MTX polyglutamation and enhanced folic acid depletion due to gene dosage effects of chromosome 21. Alteration of folate metabolism and/or vitamin B12 levels through intravenous or intrathecal administration of MTX might exist, although vitamin B12 and other essential nutrients were managed using intravenous hyperalimentation. To the best of our knowledge, this is the first report of an autopsy case that shows myelopathy mimicking SACD in a DS patient accompanied by B lymphoblastic leukemia. The case suggests a pathophysiological mechanism of MTX‐related myelopathy in DS patients with B lymphoblastic leukemia mimicking SACD.Keywords
This publication has 26 references indexed in Scilit:
- Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cordJournal of Clinical Neuroscience, 2013
- Lateral and Dorsal Column Hyperintensity on Magnetic Resonance Imaging in a Patient with Myelopathy Associated with Intrathecal ChemotherapyCase Reports in Neurology, 2013
- MR Findings of Intrathecal Chemotherapy‐Related Myelopathy in Two Cases: Mimicker of Subacute Combined DegenerationJournal of Neuroimaging, 2007
- `Anesthesia paresthetica'Neurology, 1995
- Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1991
- Methotrexate-related multifocal axonopathyActa Neuropathologica, 1989
- Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemiaCancer, 1978
- The central nervous system in childhood leukemia.III. mineralizing microangiopathy and dystrophic calcificationCancer, 1978
- Parenchymatous degeneration of the central nervous system in childhood leukemiaCancer, 1974
- Encephalopathy in Acute Leukaemia Associated with Methotrexate TherapyArchives of Disease in Childhood, 1972